Hepatosplenic T-Cell Non-Hodgkin Lymphoma Cured with Tandem Autologous and Allogeneic Stem Cell Transplantation

IF 2 4区医学 Q3 ONCOLOGY

Chemotherapy Pub Date : 2022-05-10 DOI:10.1159/000524891

G. Lolli, B. Casadei, V. Stefoni, L. Argnani, F. Bonifazi, P. Zinzani

引用次数: 0

Abstract

Hepatosplenic T-cell lymphoma is a very difficult lymphoma to deal with, almost impossible to cure. “Tandem” consolidation therapy with auto-stem cell transplant and allo-stem cell transplant can induce a long-lasting response and potentially cure this disease.

查看原文本刊更多论文

自体和异体干细胞串联移植治疗肝脾t细胞非霍奇金淋巴瘤

肝脾t细胞淋巴瘤是一种很难治疗的淋巴瘤，几乎不可能治愈。自体干细胞移植和同种异体干细胞移植的“串联”巩固治疗可以诱导持久的反应，并有可能治愈这种疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemotherapy 医学-药学

CiteScore

5.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.